drugset / Trial / NCT00136110

Trial of Sodium Valproate in Amyotrophic Lateral Sclerosis

NCT00136110

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether the use of sodium valproate is effective in slowing the disease progression in Amyotrophic Lateral Sclerosis.

Timeline

Start
2005-04
Primary completion
Completion
2007-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Valproate Small molecule 1500 mg